✦ LIBER ✦

503 Durability of HBeAg seroconversion following adefovir dipivoxil treatment for chronic hepatitis B (CHB)

✍ Scribed by T.T. Chang; M.L. Shiffman; M. Tong; Y.E. Liaw; P. Komolmit; J. Sorbel; S. Arterburn; E. Mondou; S. Chuck; P. Marcellin

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P.104 Durability of HBeAg seroconversion

✍ T.T. Chang; M.L. Shiffman; M. Tong; Y.F. Liaw; P. Komolmit; J. Sorbel; S. Arterb 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 134 KB

424 Durability of HBEAG seroconversion a

✍ T.T. Chang; M. Shiffman; M. Tong; P. Marcellin; Y.F. Liaw; P. Luengrojanakul; G. 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 63 KB

Resistance surveillance of HBEAG— chroni

✍ S. Xiong; H. Yang; C.E. Westland; W.E. Delaney IV; D. Colledge; A. Bartholomeusz 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 162 KB

18 OUTCOME OF HBeAg-NEGATIVE CHRONIC HEP

✍ S. Hadziyannis; V. Sevastianos; I. Rapti 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 70 KB

OL-047 Long-term therapy with adefovir d

✍ J. You; L. Zhuang; H.Y. Chen; X. Feng; L. Kong; H. Lei; Y.L. Ma; Y.L. Li; W.B. Y 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Predicting HBEAG loss by HBV DNA early k

✍ A.U. Neumann; Y. Havlin; T. Ronen; M. Tsiang; M. Wulfsohn; C. Brosgart; J. Fry; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 148 KB